Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,942 | -3,401 | -17,192 | -11,614 | -10,388 |
| Depreciation Amortization | 128 | 64 | 265 | 199 | 134 |
| Accounts receivable | 254 | N/A | N/A | N/A | -341 |
| Other Working Capital | 175 | -836 | -496 | -537 | -1,502 |
| Other Operating Activity | 639 | 1,110 | -3,035 | -5,221 | 1,333 |
| Operating Cash Flow | $-4,746 | $-3,063 | $-20,458 | $-17,173 | $-10,764 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 2,211 | 2,015 | 2,009 |
| PPE Investments | N/A | N/A | -18 | -18 | N/A |
| Investing Cash Flow | $0 | $N/A | $2,193 | $1,997 | $2,009 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,909 | 2,539 | 18,978 | 15,626 | 8,529 |
| Financing Cash Flow | $6,909 | $2,539 | $18,978 | $15,626 | $8,529 |
| Beginning Cash Position | 1,485 | 1,485 | 772 | 772 | 772 |
| End Cash Position | 3,648 | 961 | 1,485 | 1,222 | 546 |
| Net Cash Flow | $2,163 | $-524 | $713 | $450 | $-226 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,746 | -3,063 | -20,458 | -17,173 | -10,764 |
| Capital Expenditure | N/A | N/A | -18 | -18 | N/A |
| Free Cash Flow | -4,746 | -3,063 | -20,476 | -17,191 | -10,764 |